The market is segmented based on Global Next-Gen Sequencing for Rare Disease Diagnosis Market Segmentation, By Product Type (Reagents & Consumables, Instruments, and Software), Technology (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), and Targeted Sequencing, RNA Sequencing), Application (Rare Genetic Diseases, Cancer, Neurological Disorders, and Infectious Diseases), End-User (Hospitals, Diagnostic Laboratories, Research Institutes, and Pharmaceutical & Biotech Companies) – Industry Trends and Forecast to 2032
.
The Global Next Gen Sequencing For Rare Disease Diagnosis Market size was valued at USD 1.44 USD Million in 2024.
The Global Next Gen Sequencing For Rare Disease Diagnosis Market is projected to grow at a CAGR of 8.1% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.